|
NAA16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62569957495862E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.87974113841483E-13 |
| Normal-vs-Stage2 |
2.03280003940876E-09 |
| Normal-vs-Stage3 |
2.19739781925909E-11 |
| Normal-vs-Stage4 |
7.21311899098964E-12 |
| Stage1-vs-Stage2 |
3.050000E-01 |
| Stage1-vs-Stage3 |
1.526640E-01 |
| Stage1-vs-Stage4 |
2.751600E-02 |
| Stage2-vs-Stage3 |
9.525200E-01 |
| Stage2-vs-Stage4 |
3.612600E-01 |
| Stage3-vs-Stage4 |
3.655600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11910480882216E-13 |
| Normal-vs-AfricanAmerican |
1.80999999999099E-06 |
| Normal-vs-Asian |
5.09390000180687E-08 |
| Caucasian-vs-AfricanAmerican |
8.927400E-01 |
| Caucasian-vs-Asian |
7.540000E-01 |
| AfricanAmerican-vs-Asian |
7.314400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.21640516840216E-11 |
| Normal-vs-Female |
1.62636570877339E-12 |
| Male-vs-Female |
5.237400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.06659167345924E-12 |
| Normal-vs-Age(41-60Yrs) |
1.8612000829421E-11 |
| Normal-vs-Age(61-80Yrs) |
1.65345515057425E-12 |
| Normal-vs-Age(81-100Yrs) |
2.31229999999583E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.102400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.854250E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.516000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.768780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.582000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.257800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.539440E-03 |
| Classical-VS-Follicular |
1.343560E-02 |
| Classical-VS-Other |
6.275400E-01 |
| Classical-VS-Normal |
8.7083673605548E-12 |
| Tall-VS-Follicular |
3.454800E-01 |
| Tall-VS-Other |
2.190400E-01 |
| Tall-VS-Normal |
6.62347954261122E-12 |
| Follicular-VS-Other |
2.254600E-01 |
| Follicular-VS-Normal |
5.75828273952084E-12 |
| Other-VS-Normal |
4.330200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48769885299771E-14 |
| Normal-vs-N1 |
4.11429999958024E-07 |
| N0-vs-N1 |
4.503600E-01 |
|
|
